IMPLEMENTATION LEVEL

NFI

AFFECTED FLOW

Inflow

ANNOUNCED AS TEMPORARY

No

NON-TRADE-RELATED RATIONALE

No

ELIGIBLE FIRMS

firm-specific

JUMBO

No

TARIFF PEAK

No
← back to the state act
Inception date: 24 Mar 2016 | Removal date: open ended
Still in force

Capital injection and equity stakes (including bailouts)

On March 24, 2016, the Innovation Network Corporation of Japan (INCJ) bought 3.5 billion yen (30 million USD) worth of shares in Stella Pharma Co. The investment relates to the boron isotope enrichment technology for boron drugs.

About the Innovation Network Corporation of Japan (INCJ)
In 2009, INCJ was created as a public-private investment fund to financially support industries "next-generation businesses". INCJ supports projects that "combine technologies and varied expertise across industries and materialize open innovation.". According to the INCJ website, the fund has an investment capacity of up to USD 20 billion. Although characterized as a public-private partnership, in fact only 0.1 billion of the 2.6 billion USD invested in the fund was provided by the private sector. The rest came from the Japanese government. Of the 0.1 billion USD said to be contributed by the private sector, 13.6 million USD was in fact provided by the Development Bank of Japan, a state-owned bank. 

AFFECTED COUNTRIES

MAP
TABLE
EXPORT

AFFECTED SECTORS AND PRODUCTS

342 Basic inorganic chemicals n.e.c.
2804 Hydrogen, rare gases and other nonmetals.
280450 Boron; tellurium
352 Pharmaceutical products

Please report this page in case you detect an inaccuracy in its content.